Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Value and Molecular Mechanisms of Proteasome 26S Subunit, Non-ATPase Family Genes for Pancreatic Ductal Adenocarcinoma Patients after Pancreaticoduodenectomy

1 Feb 2021

Abstract excerpt

Objective: Pancreatic cancer (PC) is an extremely malignant tumor with similar morbidity and mortality and lack of an effective treatment. This study explored the prognostic value and molecular mechanisms of proteasome 26S subunit, non-ATPase (PSMD) family genes in pancreatic ductal adenocarcinoma (PDAC).Methods: Survival analyses were performed to elucidate the relationship between prognosis and the level of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Pancreatic and Hepatic Oncology Research
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33525943
DOI: 10.1080/08941939.2020.1863527

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Value and Molecular Mechanisms of Proteasome 26S Subunit, Non-ATPase Family Genes for Pancreatic Ductal Adenocarcinoma Patients after PancreaticoduodenectomyPMID 33525943Read ↗

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic AdenocarcinomaSemantic proximity Read ↗

USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune InfiltrationSemantic proximity Read ↗

Prognostic Value of BTNL9 Combined with Genes of Proteasome and Ubiquitin System in Pancreatic CancerSemantic proximity Read ↗

Identifying Proteasome 26S Subunit, ATPase ( <i>PSMC</i> ) Family Genes as the Prognostic Indicators and Therapeutic Targets in Lung AdenocarcinomaSemantic proximity Read ↗

Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinomaSemantic proximity Read ↗

Identification of Blood-based Non-invasive Biomarkers and Therapeutic Agents against Pancreatic Ductal Adenocarcinoma (PDAC): A Network-based StudySemantic proximity Read ↗

Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasetsSemantic proximity Read ↗

Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasetsSemantic proximity Read ↗

Integrated bioinformatics analysis of potential biomarkers for pancreatic cancerSemantic proximity Read ↗

Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.